• ORBIS Project

    We are happy and proud to announce that on 1st March 2018 the realisation of a prestigious, international and intersectoral project no. 778051 entitled ORBIS (Open Research Biopharmaceutical Internships Support) has begun. The four-year-long (2018-2022) grant was favourably evaluated in the Research and Innovation Staff Exchange (RISE) call under the Maria Skłodowska-Curie Actions of Horizon 2020 Framework Programme (H2020-MSCA-RISE-2017). This is a great success for Poznan University of Medical Sciences in particular since for the first time the Faculty of Pharmacy of our university will be the consortium leader for 9 academic and commercial institutions from Europe and the USA in a research project of such broad scale, impact and prestige.

    4 academies, 1 research institute and 4 pharmaceutical companies from 7 countries will participate in the ORBIS project, which is coordinated by Prof. Janina Lulek of the Department of Pharmaceutical Technology at PUMS Faculty of Pharmacy. Among our consortium partners are: Pharmaceutical Research Institute (Poland), Trinity College Dublin (Ireland), University of Helsinki (Finland), Applied Process Company Ltd. (Ireland), Farmak JSC (Ukraine), Physiolution GmbH (Germany), Zentiva k.s. (Czech Republic) and Rutgers University (USA).

    More about ORBIS project at http://orbisproject.eu. We also encourage all interested parties to like and follow #ORBISproject profiles on Facebook, Twitter and ResearchGate.